Highfield Biopharmaceuticals Corporation
Clinical trials sponsored by Highfield Biopharmaceuticals Corporation, explained in plain language.
-
New drug duo takes on recurrent brain cancer
Disease control Recruiting nowThis study tests whether an investigational drug called HF1K16, when combined with the approved drug bevacizumab, can help people with recurrent or progressive glioma—a type of brain tumor. The trial enrolls about 30 adults whose tumors have returned or worsened after prior treat…
Phase: PHASE2 • Sponsor: HighField Biopharmaceuticals Corporation • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Smart chemo: new drug aims to hit HER-2 cancers harder
Disease control Recruiting nowThis early-phase trial is testing a new drug called HF158K1 in 84 adults with advanced solid tumors that have HER-2 protein. The drug is a form of chemotherapy wrapped in a fat bubble that carries a targeting molecule to seek out HER-2 cancer cells. The main goals are to check sa…
Phase: PHASE1 • Sponsor: HighField Biopharmaceuticals Corporation • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC